ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,157,000 | -19.2% | 253,807 | -11.1% | 0.01% | -25.0% |
Q3 2016 | $3,909,000 | +50.1% | 285,532 | -19.0% | 0.01% | +50.0% |
Q2 2016 | $2,605,000 | +7.7% | 352,467 | -6.9% | 0.01% | 0.0% |
Q1 2016 | $2,419,000 | -35.1% | 378,568 | -36.5% | 0.01% | -27.3% |
Q4 2015 | $3,728,000 | -15.3% | 596,448 | -20.9% | 0.01% | -21.4% |
Q3 2015 | $4,401,000 | -37.1% | 753,679 | -10.9% | 0.01% | -17.6% |
Q2 2015 | $6,993,000 | +19.1% | 845,615 | +18.7% | 0.02% | +21.4% |
Q1 2015 | $5,870,000 | +49.5% | 712,320 | +24.7% | 0.01% | +40.0% |
Q4 2014 | $3,926,000 | +30.0% | 571,443 | +2.2% | 0.01% | +42.9% |
Q3 2014 | $3,021,000 | -8.4% | 559,392 | +8.1% | 0.01% | -12.5% |
Q2 2014 | $3,297,000 | -39.6% | 517,570 | -23.6% | 0.01% | -50.0% |
Q1 2014 | $5,459,000 | +44.0% | 677,369 | +21.8% | 0.02% | +33.3% |
Q4 2013 | $3,792,000 | -43.0% | 556,030 | +53.8% | 0.01% | -50.0% |
Q3 2013 | $6,651,000 | +12.9% | 361,471 | +7.3% | 0.02% | -4.0% |
Q2 2013 | $5,890,000 | – | 336,767 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |